trending Market Intelligence /marketintelligence/en/news-insights/trending/mrxjvbuvpxnt1yjtsxdryq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Depomed changes name to Assertio Therapeutics

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Depomed changes name to Assertio Therapeutics

Depomed Inc. said it changed its name to Assertio Therapeutics Inc. following shareholder approval.

In connection with the name change, Depomed's shares will trade on the Nasdaq Global Select Market under the new symbol ASRT beginning Aug. 15.

According to the company, the Assertio name reflects its renewed commitment to the advancement of patient care in the core areas of neurology, orphan and specialty medicines.

Depomed also completed the relocation of its corporate headquarters from Newark, Calif., to Lake Forest, Ill.